Wherein, the optimal AnCar‐ExoLaIMTS3 can efficiently deliver therapeutic contents to pro‐inflammatory macrophages mainly through TLR4‐mediated endocytosis, which ameliorates the severity of arthritis without obvious toxicity. The gene discussed is TLR4; the disease is arthritic joint disease.